ARTICLE | Management Tracks
Plus: Harald Reinhart retires at Zai Lab and updates from Skyhawk, Crossject, Neurona and Coulter Partners
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
June 12, 2024 7:24 PM UTC
Kenneth Mills will step down as president and CEO of RegenxBio Inc. (NASDAQ:RGNX) to become chair on July 1. COO Curran Simpson will succeed Mills, who co-founded the AAV gene therapy company in 2009. RegenxBio also named board member Daniel Tassé as lead independent director, a role previously held by Jerry Karabelas. Karabelas will remain on the board, as will co-founder and outgoing Chair Allan Fox.
Harald Reinhart will retire from Zai Lab Ltd. (NASDAQ:ZLAB; HKEX:9688) as head of global development for neuroscience, autoimmune and infectious diseases and become senior adviser. Rafael Amado, president and head of global oncology R&D, will lead global R&D upon Reinhart’s retirement as president, head of global R&D…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652674/mills-to-step-down-as-regenxbio-ceo-becomes-chair